Concomitant chemoradiotherapy for patients with nonmetastatic breast carcinoma

Macquart-Moulin, G; Viens, Patrice; Genre, Dominique; Bouscary, Marie-Laure; Resbeut, M.; Gravis, Gwénaëlle; Camerlo, Jacques; Maraninchi, D; Moatti, Jean‐Paul

doi:10.1002/(sici)1097-0142(19990515)85:10<2190::aid-cncr13>3.0.co;2-p

Cited by 33 publications

(7 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…22 This instrument measures both the patient's generic anxiety profile (trait anxiety, 20 items) and anxiety when confronted with a specific situation (state anxiety, 20 items). 15,[23][24][25] A higher score (range, 20-80) indicates a higher level of anxiety. For all patients, state-anxiety levels were evaluated before (T0), during (T1), and at the end (T2) of chemotherapy.…”

Section: Questionnairessupporting

confidence: 87%

Full access to medical records does not modify anxiety in cancer patients

Gravis

Protière

Eisinger

et al. 2011

Cancer

Self Cite

View full text Add to dashboard Cite

BACKGROUND: Information is crucial for increasing the patients' empowerment and autonomy in relevant decisionmaking processes, especially in malignant diseases. However, the extent to which information should be delivered is debated. The objective of this study was to assess the impact of providing systematic full access (SFA) to the medical record on anxiety, quality of life, and satisfaction. METHODS: Patients with newly diagnosed breast cancer, colon cancer, or lymphoma who had received adjuvant chemotherapy in an outpatient setting were included in a randomized controlled trial comparing those who requested access (RA) and those who provided SFA to the medical record. Anxiety was assessed using the Spielberger State-Trait Anxiety Inventory before, during, and at the end of treatment. Quality of life was evaluated using the European Organization for Research and Cancer quality-of-life questionnaire (EORTC QLQ-C30) before and at the end of treatment. Patients' satisfaction and perception of the organized medical record (OMR) were evaluated using a specifically designed questionnaire at the end of treatment. RESULTS: Most patients (98%) who had the opportunity to obtain the OMR chose to do so. Anxiety levels did not increase in the SFA arm, although they did not differ significantly compared with anxiety levels in the RA arm. The patients who had full access to their medical record were more satisfied with information (odds ratio, 1.68; 95% confidence interval, 0.98-2.9) and felt sufficiently informed more often (odds ratio, 1.86; 95% confidence interval, 1.08-3.19), but the differences were not statistically significant at the 5% level. CONCLUSIONS: Allowing full access to personal medical records increased satisfaction without increasing anxiety in patients with newly diagnosed cancer. Patients' autonomy and empowerment, which are now considered the ethical gold standard in industrialized countries, require access to information as a prerequisite.1-5 After a diagnosis of malignant disease, missing or insufficient information concerning the disease and its prognosis, the therapeutic options, and their side effects can significantly impair the patient's quality of life. There is evidence in the literature that the majority of cancer patients would like to receive as much information as possible from their physicians.5,6-11 Indeed, detailed information on the disease is important for the patient to make informed decisions regarding treatment options.5 It also allows the patient and his or her family to cope better with the disease and its implications. 8Information can be provided from physicians and medical staff to patients in different ways, but the most is verbal communication. However, the quality of this form of interaction is limited by the lack of time for a comprehensive discussion, semantic problems between physicians and patients, and the inability of the patient to recall all the information provided during a single visit. 12,13 It has been demonstrated that patients remember 50% to 60% of the inform...

show abstract

Section: Questionnairessupporting

confidence: 87%

Full access to medical records does not modify anxiety in cancer patients

Gravis

Protière

Eisinger

et al. 2011

Cancer

Self Cite

View full text Add to dashboard Cite

show abstract

“…As a result of chemotherapy, patients with cancer frequently experience changes in mental state, manifested as feelings of depression, helplessness, anxiety, and difficulty in concentrating (Cimprich, 1999;Coons, Leventhal, Nerenz, Love, & Larson, 1987;Munkres, Oberst, & Hughes, 1992). Symptom distress or discomfort stemming from symptoms interferes with a person's ability to perform activities of daily living and affects quality of life (Cimprich;Grant, 1997;Macquart-Moulin et al, 1999;Pickett, 1991).…”

Section: Background Chemotherapy-associated Symptomsmentioning

confidence: 99%

Virtual Reality: A Distraction Intervention for Chemotherapy

Schneider

Hood²

2007

Oncology Nursing Forum

160

150

View full text Add to dashboard Cite

Purpose/Objectives-To explore virtual reality (VR) as a distraction intervention to relieve symptom distress in adults receiving chemotherapy treatments for breast, colon, and lung cancer. Design-Crossover design in which participants served as their own control.Setting-Outpatient clinic at a comprehensive cancer center in the southeastern United States. Sample-123 adults receiving initial chemotherapy treatments.Methods-Participants were randomly assigned to receive the VR distraction intervention during one chemotherapy treatment and then received no intervention (control) during an alternate matched chemotherapy treatment. The Adapted Symptom Distress Scale-2, Revised Piper Fatigue Scale, and State Anxiety Inventory were used to measure symptom distress. The Presence Questionnaire and an open-ended questionnaire were used to evaluate the subjects' VR experience. The influence of type of cancer, age, and gender on symptom outcomes was explored. Mixed models were used to test for differences in levels of symptom distress. Main Research Variables-Virtual reality and symptom distress.Findings-Patients had an altered perception of time (p < 0.001) when using VR, which validates the distracting capacity of the intervention. Evaluation of the intervention indicated that patients believed the head-mounted device was easy to use, they experienced no cybersickness, and 82% would use VR again. However, analysis demonstrated no significant differences in symptom distress immediately or two days following chemotherapy treatments.Conclusions-Patients stated that using VR made the treatment seem shorter and that chemotherapy treatments with VR were better than treatments without the distraction intervention. However, positive experiences did not result in a decrease in symptom distress. The findings support the idea that using VR can help to make chemotherapy treatments more tolerable, but clinicians should not assume that use of VR will improve chemotherapy-related symptoms.Implications for Nursing-Patients found using VR during chemotherapy treatments to be enjoyable. VR is a feasible and cost-effective distraction intervention to implement in the clinical setting.Cancer continues to be a major health problem in the United States. Chemotherapy is prescribed either prior to or after surgery in an attempt to diminish tumor mass, eradicate occult micrometastatic disease, and increase disease-free survival. The chances for survival are enhanced if patients receive all of the recommended chemotherapy treatments for their specific disease. However, because of associated chemotherapy-related distress symptoms, patients often have difficulty adhering to the prescribed schedule. Developing interventions to assist Author Contact: Susan M. Schneider, PhD, RN, AOCN®, can be reached at susan.schneider@duke.edu, with copy to editor at ONFEditor@ons.org.. people to better tolerate cancer treatments and, therefore, increase their chances for survival is an oncology nursing priority and a major focus of oncology nursing research. ...

show abstract

“…Fatigue is multidimensional and can be described in terms of perceived energy, mental capacity, and psychologic status [2,3]. It can impair daily functioning and lead to negative effects on quality of life [4][5][6][7], self-care capabilities [8], and desire to continue treatment [9]. In some cases, fatigue is the most significant barrier to functional recovery in cancer patients with stable disease who are undergoing chemotherapy [10].…”

Section: Introductionmentioning

confidence: 99%

“…Fatigue has been reported in 80% to 99% of cancer patients who undergo treatment with chemotherapy, radiotherapy, or both [5,12,14,15]. Although the relative importance of physical (e.g., anemia, cachexia), psychological (e.g., depression, anxiety), and situational (e.g., sleep deprivation) factors is usually unclear [2,9,10,14,16,17], these and other factors appear to be important in the pathogenesis and may be predominant in some cases.…”

Section: Introductionmentioning

confidence: 99%

Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition

et al. 2000

View full text Add to dashboard Cite

Purpose. This survey was designed to confirm the prevalence and duration of fatigue in the cancer population and to assess its physical, mental, social, and economic impacts on the lives of patients and caregivers.Patients and Methods. A 25-minute telephone interview was completed with 379 cancer patients having a prior history of chemotherapy. Patients were recruited from a sample of 6,125 households in the United States identified as having a member with cancer. The median patient age was 62 years, and 79% of respondents were women. Patients reporting fatigue at least a few times a month were asked a series of questions to better describe their fatigue and its impact on quality of life.Results. Seventy-six percent of patients experienced fatigue at least a few days each month during their most recent chemotherapy; 30% experienced fatigue on a daily basis. Ninety-one percent of those who experienced fatigue reported that it prevented a "normal" life, and 88% indicated that fatigue caused an alteration in their daily routine. Fatigue made it more difficult to participate in social activities and perform typical cognitive tasks. Of the 177 patients who were employed, 75% changed their employment status as a result of fatigue. Furthermore, 65% of patients indicated that their fatigue resulted in their caregivers taking at least one day (mean, 4.5 days) off work in a typical month. Physicians were the health care professionals most commonly consulted (79%) to discuss fatigue. Bed rest/ relaxation was the most common treatment recommendation (37%); 40% of patients were not offered any recommendations.Conclusions. Cancer-related fatigue is common among cancer patients who have received chemotherapy and results in substantial adverse physical, psychosocial, and economic consequences for both patients and caregivers. Given the impact of fatigue, treatment options should be routinely considered in the care of patients with cancer.

show abstract

Concomitant chemoradiotherapy for patients with nonmetastatic breast carcinoma

Cited by 33 publications

References 27 publications

Full access to medical records does not modify anxiety in cancer patients

Full access to medical records does not modify anxiety in cancer patients

Virtual Reality: A Distraction Intervention for Chemotherapy

Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition

Contact Info

Product

Resources

About